ISIN | LU2040176112 |
---|---|
Valor Number | 49405956 |
Bloomberg Global ID | |
Fund Name | Swisscanto (LU) Equity Fund Committed Europe Top Dividend CA |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | Swisscanto Fondsleitung AG |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The sub-fund assets will be invested in an investment universe dedicated to companies with a high dividend yield and which have their registered office or conduct the majority of their business operations in the geographical region referred to in the name of the sub-fund. |
Peculiarities |
Current Price * | 129.95 EUR | 25.04.2025 |
---|---|---|
Previous Price * | 129.66 EUR | 24.04.2025 |
52 Week High * | 135.80 EUR | 19.03.2025 |
52 Week Low * | 116.88 EUR | 09.04.2025 |
NAV * | 129.95 EUR | 25.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 30,601,500 | |
Unit/Share Assets *** | 2,331,380 | |
Trading Information SIX |
YTD Performance | +5.73% |
31.12.2024 - 25.04.2025
31.12.2024 25.04.2025 |
---|---|---|
YTD Performance (in CHF) | +6.25% |
31.12.2024 - 25.04.2025
31.12.2024 25.04.2025 |
1 month | -4.10% |
25.03.2025 - 25.04.2025
25.03.2025 25.04.2025 |
3 months | +2.49% |
27.01.2025 - 25.04.2025
27.01.2025 25.04.2025 |
6 months | +2.25% |
25.10.2024 - 25.04.2025
25.10.2024 25.04.2025 |
1 year | +8.32% |
25.04.2024 - 25.04.2025
25.04.2024 25.04.2025 |
2 years | +15.09% |
25.04.2023 - 25.04.2025
25.04.2023 25.04.2025 |
3 years | +18.11% |
25.04.2022 - 25.04.2025
25.04.2022 25.04.2025 |
5 years | +64.54% |
27.04.2020 - 25.04.2025
27.04.2020 25.04.2025 |
Equity Participation Rate in % | 97.55 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Shell PLC | 4.21% | |
---|---|---|
Allianz SE | 4.02% | |
Roche Holding AG | 3.74% | |
AXA SA | 3.36% | |
Swiss Re AG | 3.19% | |
Novartis AG Registered Shares | 3.19% | |
GSK PLC | 3.13% | |
Zurich Insurance Group AG | 3.07% | |
Sanofi SA | 3.05% | |
Unilever PLC | 2.89% | |
Last data update | 31.03.2025 |
TER | 0.92% |
---|---|
TER date | 28.03.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 1.10% |
Ongoing Charges *** | 0.93% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |